High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Stopped early · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: High doses of esterified estrogens may stop the growth of breast cancer cells that no longer respond to hormone therapy. PURPOSE: This phase II trial is studying how well high-dose esterified estrogens work in treating postmenopausal women with metastatic breast cancer that has failed previous hormone therapy.
Key facts
- Study ID
- NCT00131924
- Run by
- Northwestern University
- People needed
- 1
- Starts
- 2004-03-01
- Expected to finish
- 2006-01-01
- Last updated by the study team
- 2012-06-11
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.